Associate Professor of Ophthalmology, Johns Hopkins University School of Medicine
Ophthalmology
Dr. Elia J. Duh, MD
|
|
Give Review
Elia works in the field of Ophthalmology. He researched medicine at Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Elia is a published doctor and has 51 publications published. The lastest was: 'Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence.' Elia accepts Medicare payments and is listed with Medicare.gov.
Publications
- Neuroprotective role of Nrf2 for retinal ganglion cells in ischemia-reperfusion.
- NRF2 plays a protective role in Diabetic retinopathy in mice.
- Long-term Outcomes in Ranibizumab-Treated Patients With Retinal Vein Occlusion; The Role of Progression of Retinal Nonperfusion.
- Nrf2 acts cell-autonomously in endothelium to regulate tip cell formation and vascular branching.
- Hypoxic retinal Muller cells promote vascular permeability by HIF-1-dependent up-regulation of angiopoietin-like 4.
- Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo.
- MEF2C Ablation in Endothelial Cells Reduces Retinal Vessel Loss and Suppresses Pathologic Retinal Neovascularization in Oxygen-Induced Retinopathy.
- Inhibition of pathological retinal angiogenesis by the integrin ?v?3 antagonist tetraiodothyroacetic acid (tetrac).
- Sema 3A resists retinal revascularization.
- Pigment Epithelium-Derived Factor Regulates Lipid Metabolism via Adipose Triglyceride Lipase.
- Nrf2 has a protective role against neuronal and capillary Degeneration in retinal ischemia-reperfusion injury.
- TNFalpha is required for late BRB breakdown in Diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis.
- Antipermeability function of PEDF involves blockade of the MAP kinase/GSK/beta-catenin signaling pathway and uPAR expression.
- Pigment epithelium-derived factor contributes to insulin resistance in obesity.
- Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells.
- Renaming the DSCR1/Adapt78 gene family as RCAN: regulators of calcineurin.
- Tissue factor pathway inhibitor-2 is upregulated by vascular endothelial growth factor and suppresses growth factor-induced proliferation of endothelial cells.
- Vascular endothelial growth factor upregulates expression of ADAMTS1 in endothelial cells through protein kinase C signaling.
- Use of topical human amniotic fluid in the treatment of acute Ocular alkali injuries in mice.
- A system for inducible gene expression in retinal ganglion cells.
- Persistence of fetal vasculature in a patient with Knobloch syndrome: potential role for endostatin in fetal vascular remodeling of the eye.
- VEGF selectively induces Down syndrome critical region 1 gene expression in endothelial cells: a mechanism for feedback regulation of angiogenesis?
- Increased expression of iron-regulating genes in monkey and human Glaucoma.
- Vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor: implications for Ocular angiogenesis.
- Long-term survival in a patient with uveal melanoma and liver metastasis.
- Retinal neuroprotection against ischemic injury mediated by intraOcular gene transfer of pigment epithelium-derived factor.
- Periocular gene transfer of sFlt-1 suppresses ocular Neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier.
- Pigment epithelium-derived factor suppresses ischemia-induced retinal Neovascularization and VEGF-induced migration and growth.
- Inducible expression of vascular endothelial growth factor in adult mice causes severe proliferative Retinopathy and retinal detachment.
- Periocular injection of an adenoviral vector encoding pigment epithelium-derived factor inhibits Choroidal neovascularization.
- Bilateral iris Neovascularization as the initial sign of obesity-hypoventilation (Pickwickian) syndrome: hypoxia/hypercapnia as a stimulus for angiogenesis.
- Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat.
- Upregulation of placental growth factor by vascular endothelial growth factor via a post-transcriptional mechanism.
- Different effects of angiopoietin-2 in different vascular beds: new vessels are most sensitive.
- Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.
- Activation of the human immunodeficiency virus long terminal repeat by herpes simplex virus type 1 is associated with induction of a nuclear factor that binds to the N...
- Use of a marked erythropoietin gene for investigation of its cis-acting elements.
- Hypoglycemia-induced angina pectoris in a patient with diabetes mellitus.
- Regulation of retinal hemodynamics in Diabetic rats by increased expression and action of endothelin-1.
- The bZIP transcription factor Nrl stimulates rhodopsin promoter activity in primary retinal cell cultures.
- Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective in...
- Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence.
- Vascular endothelial growth factor and diabetes: the agonist versus antagonist paradox.
- Pigment epithelium-derived factor inhibits retinal and Choroidal neovascularization.
- Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes.
- Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and ...
- Identification of novel genes preferentially expressed in the retina using a custom human retina cDNA microarray.
- AAV-mediated gene transfer of pigment epithelium-derived factor inhibits Choroidal neovascularization.
- Protein transport to choroid and retina following periOcular injection: theoretical and experimental study.
- Stimulation of Neovascularization by the anti-angiogenic factor PEDF.
Schools
Harvard Medical School
Duke University Med Center
Johns Hopkins University School Med
Procedures Preformed
- Cataract Removal Surgery
- Destruction of Lesion of Retina and Choroid
- Repair of Retinal Detachment or Retinal Tear
Conditions Treated
- Age-Related Macular Degeneration
- Aphakia and Other Disorders of Lens
- Bell's Palsy
- Blepharitis
- View All
Doctors Specialties
- Ophthalmology
Accepted Insurances
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Preferred PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Southern Health PPO
- Emblem Health
- First Health (Coventry Health Care) PPO
- Geisinger Health Plan
- Choice Care PPO
- Kaiser Permanente
- Mail Handlers Benefit Plan (MHBP)
- MedHealthInsurance
- Medicaid
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Tricare
- Choice Plus POS
- Navigate HMO
- Options PPO
- United Healthcare
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Duke University Hospital -
Harvard Medical School
Hospital
-
Johns Hopkins Bayview Medical Center -
Johns Hopkins Hospital
Drug Facts
| NPI NUMBER | 1114974318 | |
| NPPES Provider LastName | DUH | |
| NPPES Provider FirstName | ELIA | |
| NPPES Provider ZIPCode | 212870005 | |
| NPPES Provider State | MD | |
| Specialty Description | Ophthalmology | |
| Total Claim Count | 60.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1114974318 |
| Last Name Of The Provider | DUH |
| First Name Of The Provider | ELIA |
| View All |
Similar Doctors
|
|
Dr. John Gambrill Jr., MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert A. Loeb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Esther I. Chang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pavle Doroslovacki, MD |
|
|
Dr. Shiri Zayit-Soudry, MD |
|
|
Dr. Suzanne W. Van Landingham, MD |
|
|
Dr. Lloyd B. Williams, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Brinda Muthusamy, MB CHB
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard B. Jenkins, MD |
|
|
Dr. Angelique J. Pillar, MD
This Doctor is OpenDoctor Recommended.
|